Armune Appoints CFO To Ready Launch Of Prostate Cancer Detection Test
KALAMAZOO - After recently completing the first close on a $2.5 million Series A financing round, Armune BioScience Monday announced the appointment of Susan J. Crookston to the position of Chief Financial Officer to continue the company?s preparation for the launch of Apifiny, its non-PSA blood test to aid in the early detection of prostate